Neil Vasan

6.1k total citations · 2 hit papers
26 papers, 2.5k citations indexed

About

Neil Vasan is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Neil Vasan has authored 26 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 11 papers in Pulmonary and Respiratory Medicine and 11 papers in Oncology. Recurrent topics in Neil Vasan's work include PI3K/AKT/mTOR signaling in cancer (8 papers), Cancer Genomics and Diagnostics (8 papers) and Advanced Breast Cancer Therapies (6 papers). Neil Vasan is often cited by papers focused on PI3K/AKT/mTOR signaling in cancer (8 papers), Cancer Genomics and Diagnostics (8 papers) and Advanced Breast Cancer Therapies (6 papers). Neil Vasan collaborates with scholars based in United States, Japan and Spain. Neil Vasan's co-authors include David M. Hyman, José Baselga, Lewis C. Cantley, Julie L. Boyer, Roy S. Herbst, Marcus D. Goncalves, Roger J. Liang, Andrew J. Dannenberg, Jared L. Johnson and Emma M. Schatoff and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Clinical Investigation.

In The Last Decade

Neil Vasan

26 papers receiving 2.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A view on drug resistance in cancer

2019 1.9k citations Neil Vasan, José Baselga et al. Nature profile →
Dietary fructose improves intestinal cell survival and nutrient absorption

2021 194 citations Samuel Taylor, Shakti Ramsamooj et al. Nature profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Neil Vasan United States	10	1.4k	637	592	378	333	26	2.5k
Genevieve Housman United States	10	1.7k 1.3×	918 1.4×	665 1.1×	295 0.8×	255 0.8×	17	2.9k
K Lapińska United States	8	1.8k 1.3×	928 1.5×	647 1.1×	307 0.8×	261 0.8×	8	3.0k
Sung-Gil Chi South Korea	29	1.9k 1.4×	551 0.9×	574 1.0×	384 1.0×	308 0.9×	72	2.9k
Shannon Byler United States	7	1.8k 1.3×	971 1.5×	689 1.2×	319 0.8×	273 0.8×	9	3.0k
Sarah Heerboth United States	11	2.0k 1.5×	983 1.5×	710 1.2×	318 0.8×	283 0.8×	14	3.2k
Solmaz Shirjang Iran	16	1.5k 1.1×	498 0.8×	823 1.4×	227 0.6×	187 0.6×	18	2.4k
Malathy P.V. Shekhar United States	28	1.2k 0.9×	812 1.3×	488 0.8×	383 1.0×	235 0.7×	56	2.3k
Reza Bayat Mokhtari Canada	16	1.6k 1.1×	839 1.3×	808 1.4×	343 0.9×	552 1.7×	35	3.1k
Anamaria Brozović Croatia	21	1.3k 1.0×	840 1.3×	551 0.9×	201 0.5×	186 0.6×	60	2.3k
Amalia Azzariti Italy	37	1.9k 1.4×	1.4k 2.2×	601 1.0×	285 0.8×	445 1.3×	132	3.6k

Countries citing papers authored by Neil Vasan

Since Specialization

Citations

This map shows the geographic impact of Neil Vasan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Neil Vasan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Neil Vasan more than expected).

Fields of papers citing papers by Neil Vasan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Neil Vasan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Neil Vasan. The network helps show where Neil Vasan may publish in the future.

Co-authorship network of co-authors of Neil Vasan

This figure shows the co-authorship network connecting the top 25 collaborators of Neil Vasan. A scholar is included among the top collaborators of Neil Vasan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Neil Vasan. Neil Vasan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Shin, Alice E., Kensuke Sugiura, David Cohen, et al.. (2025). LIN28B-mediated PI3K/AKT pathway activation promotes metastasis in colorectal cancer models. Journal of Clinical Investigation. 135(8). 2 indexed citations

Wang, Shikun, Joshua R. Cook, Neil Vasan, et al.. (2025). Continuous glucose monitoring to characterize hyperglycemia during chemotherapy for early stage breast cancer. Breast Cancer Research and Treatment. 212(3). 511–519. 3 indexed citations

Chaki, Moumita, et al.. (2025). Retrospective comparison between breast cancer tissue- and blood-based next-generation sequencing results in detection of PIK3CA, AKT1, and PTEN alterations. Breast Cancer Research. 27(1). 122–122. 1 indexed citations

Wang, Ying, J. Raikhelkar, Neil Vasan, et al.. (2024). Abstract PO1-10-04: Racial and Ethnic Disparities in Anthracycline and HER2-targeted Cardiotoxicity in Patients With Breast Cancer Using Global Longitudinal Strain Imaging Techniques. Cancer Research. 84(9_Supplement). PO1–10. 1 indexed citations

Vasan, Neil, et al.. (2024). Concordance between tissue (tumor DNA) and liquid (ctDNA) biopsy next-generation sequencing (NGS) data in detection of PIK3CA, AKT1, and PTEN alterations in breast cancer: A retrospective analysis.. Journal of Clinical Oncology. 42(16_suppl). e15033–e15033. 2 indexed citations

Shah, Parin, Neeharika Kothapalli, Shivem B. Shah, et al.. (2024). Mapping variant effects on anti-tumor hallmarks of primary human T cells with base-editing screens. Nature Biotechnology. 43(3). 384–395. 18 indexed citations

Sivakumar, Smruthy, Dexter X. Jin, Jeffrey S. Ross, et al.. (2023). Genetic Heterogeneity and Tissue-specific Patterns of Tumors with Multiple PIK3CA Mutations. Clinical Cancer Research. 29(6). 1125–1136. 16 indexed citations

Vasan, Neil & Lewis C. Cantley. (2022). At a crossroads: how to translate the roles of PI3K in oncogenic and metabolic signalling into improvements in cancer therapy. Nature Reviews Clinical Oncology. 19(7). 471–485. 93 indexed citations

Mullangi, Samyukta & Neil Vasan. (2021). Genomic Characterization of De Novo Metastatic Breast Cancer. Clinical Breast Cancer. 22(2). 98–102. 6 indexed citations

10.

Taylor, Samuel, Shakti Ramsamooj, Roger J. Liang, et al.. (2021). Dietary fructose improves intestinal cell survival and nutrient absorption. Nature. 597(7875). 263–267. 194 indexed citations breakdown →

11.

Hyde, Parker N., John N. Falcone, Aaron Neinstein, et al.. (2021). Treating Alpelisib-Induced Hyperglycemia with Very Low Carbohydrate Diets and Sodium-Glucose Co-Transporter 2 Inhibitors: A Case Series. Integrative Cancer Therapies. 20. 1543347419–1543347419. 14 indexed citations

12.

Gorelick, Alexander N., Francisco J. Sánchez‐Rivera, Yanyan Cai, et al.. (2020). Phase and context shape the function of composite oncogenic mutations. Nature. 582(7810). 100–103. 26 indexed citations

13.

Vasan, Neil, et al.. (2020). 1954P A pan-cancer analysis of double PIK3CA mutations. Annals of Oncology. 31. S1101–S1101. 1 indexed citations

14.

Vasan, Neil, José Baselga, & David M. Hyman. (2019). A view on drug resistance in cancer. Nature. 575(7782). 299–309. 1897 indexed citations breakdown →

15.

Vasan, Neil, Pedram Razavi, Hong Shao, et al.. (2019). Double PIK3CA mutations in cis enhance PI3Kα oncogene activation and sensitivity to PI3Kα inhibitors in breast cancer. Annals of Oncology. 30. iii1–iii1. 5 indexed citations

16.

Vasan, Neil. (2017). State-of-the-Art Update: CDK4/6 Inhibitors in ER+ Metastatic Breast Cancer. 13(4). 3 indexed citations

17.

Vasan, Neil, Maria Ignez Braghiroli, Alexander N. Shoushtari, et al.. (2017). An elderly man with remote history of metastatic melanoma now with localized pancreas cancer and new liver masses. Journal of Gastrointestinal Oncology. 8(3). 596–602. 1 indexed citations

18.

Vasan, Neil, Julie L. Boyer, & Roy S. Herbst. (2014). A RAS Renaissance: Emerging Targeted Therapies for KRAS-Mutated Non–Small Cell Lung Cancer. Clinical Cancer Research. 20(15). 3921–3930. 82 indexed citations

19.

Vasan, Neil, Ozlen Saglam, & Brigid K. Killelea. (2012). Metastatic leiomyosarcoma presenting as bilateral, multifocal breast masses. BMJ Case Reports. 2012. bcr2012007188–bcr2012007188. 2 indexed citations

20.

Dooley, Gordon & Neil Vasan. (1989). Dilantin hyperplasia: a review of the literature.. PubMed. 68. 19–22. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact